| 000 | 01801 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517171934.0 | ||
| 264 | 0 | _c20180531 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1096-9071 | ||
| 024 | 7 |
_a10.1002/jmv.24870 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNovalić, Zlata | |
| 245 | 0 | 0 |
_aCytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model. _h[electronic resource] |
| 260 |
_bJournal of medical virology _c12 2017 |
||
| 300 |
_a2207-2216 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xblood |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aDNA, Viral _xgenetics |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEpstein-Barr Virus Infections _xcomplications |
| 650 | 0 | 4 |
_aGanciclovir _xadministration & dosage |
| 650 | 0 | 4 |
_aHerpesvirus 4, Human _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aNasopharyngeal Carcinoma |
| 650 | 0 | 4 |
_aNasopharyngeal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aValproic Acid _xpharmacology |
| 650 | 0 | 4 |
_aViral Load _xmethods |
| 650 | 0 | 4 | _aVirus Activation |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aVerkuijlen, Sandra A W M | |
| 700 | 1 | _aVerlaan, Mariska | |
| 700 | 1 | _aEersels, Jos L H | |
| 700 | 1 | _ade Greeuw, Inge | |
| 700 | 1 | _aMolthoff, Carla F M | |
| 700 | 1 | _aMiddeldorp, Jaap M | |
| 700 | 1 | _aGreijer, Astrid E | |
| 773 | 0 |
_tJournal of medical virology _gvol. 89 _gno. 12 _gp. 2207-2216 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jmv.24870 _zAvailable from publisher's website |
| 999 |
_c27509746 _d27509746 |
||